Products, services, reviews and techniques used in lead molecule delivery, formulation and toxicology, using assays and animal models.
ELISA for the detection of Catumaxomab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Enzyme Immunoassay for the Quantitative Determination of Emicizumab in human Serum and Plasma
ELISA for the detection of Glofitamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
ELISA for the detection of Epcoritamab in human serum and plasma. Lead time for this kit is 5 weeks. About the kit: - Uses anti-idiotypic monoclonal antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity. - Recovery rates are between 85 - 115% - Validated as per US FDA guidelines for Bioassays - Developed using the innovator drug as calibrator - Shelf life: 1 year
Immunoassay for quantitative determination of P. pastoris Host Cell Proteins
Enzyme Immunoassay for the Quantitative Determination of HEK HCP in human serum, plasma and other biological samples.
Robust and Sensitive Enzyme Immunoassay for the detection of CRM197 in biological preparations including vaccines and cell culture supernatants. Standard used is CRM197 expressed in E.coli.
The Etanercept (Enbrel) ELISA kit is intended for the quantitative determination of Etanercept (Enbrel) in serum, plasma and cell culture samples.
Enzyme Immunoassay for quantitative detection of Anti-Darbepoetin in serum and plasma.
Immunoassay for quantitative estimation of Lixisenatide in human serum, plasma and tissue extracts.
Immunoassay for quantitative estimation of Triptorelin in human serum, plasma and tissue extracts.
Enzyme Immunoassay for the quantitative determination of Ibrutinib in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of AntiAlemtuzumab in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of Benralizumab in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of Lebrikizumab in serum, plasma and cell culture supernatant
Enzyme Immunoassay for the quantitative determination of Reslizumab (CINQAIR/CINQAERO) in serum, plasma and cell culture supernatantnt
Enzyme Immunoassay for the quantitative determination of Teprotumumab in serum and plasma.
Enzyme Immunoassay for the quantitative determination of Selicrelumab in serum and plasma.
FIREWORKS provides access to a centralized data management web portal, giving users total insights and analytics into BIOFIRE ® System performance, utilization, pathogen surveillance, and workflow management.
